| Literature DB >> 30402458 |
Carla María Blanco-Lizarazo1, Indira Sotelo-Díaz2, José Luis Arjona-Roman3, René Miranda-Ruvalcaba4.
Abstract
The reduction of NaNO2 and safety in meat products have been a concern to the meat industry for the last years. This research evaluated the changes in total fatty acids (TFAs) and myoglobin forms by adding starter culture (Lactobacillus sakei/Staphylococcus carnosus) and 50 ppm of NaNO2 during salami processing. In the postripening stage, the starter culture influenced the concentration of the palmitic, oleic, vaccenic, and γ-linolenic TFAs, whereas the metmyoglobin concentration was lower (which could be related to the antioxidant effect of the starter culture). In this stage, an increase in enthalpy, specific heat, and onset temperature was found when adding starter culture and NaNO2, which is directly related to polyunsaturated TFA. However, when adding just the starter culture without 50 ppm NaNO2, the E. coli population was reduced in 4 log CFU/g. This study proposes the analysis of changes in meat product processing like salami in a holistic form, where the application of starter culture with low nitrite concentrations could be in the meat industry an upward trend for reducing this additive.Entities:
Year: 2018 PMID: 30402458 PMCID: PMC6193324 DOI: 10.1155/2018/5934305
Source DB: PubMed Journal: Int J Food Sci ISSN: 2314-5765
Changes in total fatty acids (TFAs) during salami processing expressed in mg/g of fat. Treatments with (Ls- Sc) and without (C) starter addition; the superscript indicates the addition of 50 ppm NaNO2.
|
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||||||
| Myristic acid (C14:0) |
| 4.18 ± 0.30a |
| 1.62 ± 0.19c |
| 3.11 ± 0.21a |
| 3.71 ± 0.30a |
| 3.45 ± 0.31a |
| ||
|
| 3.68 ± 0.14a |
| 3.68 ± 0.34b |
| 3.20 ± 0.00a |
| 3.36 ± 0.16a,b |
| 4.24 ± 0.81a |
| |||
| C | 3.63 ± 0.14a |
| 3.23 ± 0.48b |
| 2.41 ± 0.72b,c |
| 0.00 ± 0.00b |
| 4.09 ± 0.37a |
| |||
| C+ | 3.60 ± 0.86a |
| 5.54 ± 0.00a |
| 2.36 ± 0.59c |
| 3.38 ± 0.69a |
| 4.46 ± 0.19a |
| |||
|
| |||||||||||||
| Palmitoleic acid (C16:1) |
| 3.72 ± 0.24b,c |
| 1.27 ± 0.06c |
| 3.09 ± 0.06a |
| 2.56 ± 0.34b |
| 2.75 ± 0.24b |
| ||
|
| 3.57 ± 0.11c |
| 2.73 ± 0.60b |
| 2.03 ± 0.71b |
| 3.31 ± 0.11a |
| 2.48 ± 0.49b |
| |||
| C | 4.82 ± 0.48a |
| 2.31 ± 0.39b |
| 0.00 ± 0.00d |
| 0.00 ± 0.00b | 2.71 ± 0.65b |
| ||||
| C+ | 4.35 ± 0.40a,b |
| 4.59 ± 0.00a |
| 1.26 ± 0.00c |
| 4.99 ± 0.96a |
| 3.94 ± 0.35a |
| |||
|
| |||||||||||||
| Palmitic acid (C16:0) |
| 56.15 ± 1.10b |
| 56.33 ± 2.85c |
| 54.56 ± 3.36b |
| 57.25 ± 4.95b |
| 53.48 ± 3.60b |
| ||
|
| 58.60 ± 1.26a,b |
| 57.65 ± 4.25c |
| 63.77 ± 4.37a |
| 50.17 ± 1.49c |
| 56.05 ± 2.54b |
| |||
| C | 57.19 ± 2.94a,b |
| 72.76 ± 6.74b |
| 68.94 ± 3.97a |
| 80.59 ± 2.68a |
| 71.60 ± 5.82a |
| |||
| C+ | 59.81 ± 2.09a |
| 87.72 ± 1.48a |
| 61.20 ± 0.10d |
| 64.54 ± 3.00b |
| 72.56 ± 2.81a |
| |||
|
| |||||||||||||
| Oleic acid (C18:1) |
| 104.68 ± 0.92a |
| 91.62 ± 8.03c |
| 96.79 ± 1.46a |
| 92.63 ± 6.54a |
| 91.10 ± 6.00b |
| ||
|
| 107.12 ± 3.28a |
| 85.17 ± 8.31c |
| 86.94 ± 8.17b |
| 91.17 ± 4.75a |
| 90.24 ± 3.66b |
| |||
| C | 104.49 ± 4.21a |
| 120.2 ± 7.87b |
| 123.25 ± 3.70b |
| 121.7 ± 7.74a |
| 110.28 ± 9.05a |
| |||
| C+ | 105.28 ± 4.33a |
| 125.8 ± 1.40a |
| 116.88 ± 0.63b |
| 114.9 ± 3.37a |
| 108.34 ± 4.99a |
| |||
|
| |||||||||||||
| Vaccenic acid (C18:1 |
| 4.41 ± 0.68b |
| 1.68 ± 0.18b |
| 1.42 ± 0.00b |
| 3.09 ± 0.45b |
| 3.14 ± 0.30a |
| ||
|
| 4.38 ± 0.23b |
| 2.76 ± 0.00a |
| 3.48 ± 1.25a |
| 3.50 ± 0.03b |
| 2.43 ± 0.71a |
| |||
| C | 5.68 ± 0.88a |
| 2.71 ± 0.13a |
| 1.16 ± 0.61a |
| 4.45 ± 0.10b |
| 1.40 ± 0.02b |
| |||
| C+ | 4.42 ± 0.08b |
| 0.00 ± 0.00c |
| 1.55 ± 0.83a |
| 2.51 ± 0.41a |
| 1.37 ± 0.00b |
| |||
|
| |||||||||||||
| Stearic acid (C18:0) |
| 22.40 ± 1.38a |
| 12.60 ± 2.18a |
| 14.59 ± 1.41a |
| 14.83 ± 0.26a |
| 16.18 ± 0.33a |
| ||
|
| 18.62 ± 5.60a,b |
| 11.12 ± 1.80a |
| 9.39 ± 0.09b |
| 13.79 ± 0.81a |
| 14.16 ± 0.05c |
| |||
| C | 19.63 ± 0.72b |
| 12.48 ± 0.55a |
| 10.04 ± 0.62b |
| 7.21 ± 1.87b |
| 15.07 ± 0.16b |
| |||
| C+ | 19.74 ± 0.28b |
| 12.62 ± 1.10a |
| 11.59 ± 0.51b |
| 10.02 ± 0.81a |
| 15.75 ± 0.43a |
| |||
|
| |||||||||||||
| Linoleic acid (C18:2) |
| 0.00 ± 0.00 | 2.07 ± 0.32b |
| 4.19 ± 0.65b |
| 1.05 ± 0.06c |
| 1.62 ± 0.22c |
| |||
|
| 0.00 ± 0.00 | 2.03 ± 0.85b |
| 7.75 ± 2.94a |
| 9.88 ± 2.47b |
| 6.65 ± 0.17a |
| ||||
| C | 0.00 ± 0.00 | 4.04 ± 0.24a |
| 1.74 ± 0.60a |
| 0.00 ± 0.00 | 0.00 ± 0.00d |
| |||||
| C+ | 0.00 ± 0.00 | 4.25 ± 0.98a |
| 2.22 ± 0.79a |
| 0.00 ± 0.00 | 2.58 ± 0.00b |
| |||||
|
| |||||||||||||
|
|
| 0.00 ± 0.00 | 0.00 ± 0.00 | 1.49 ± 0.30b |
| 3.17 ± 0.02b |
| 26.62 ± 1.29a |
| ||||
|
| 0.00 ± 0.00 | 0.00 ± 0.00 | 14.16 ± 0.50a |
| 14.30 ± 0.37a |
| 30.32 ± 6.66a |
| |||||
| C | 0.00 ± 0.00 | 0.00 ± 0.00 | 1.62 ± 0.31c |
| 3.91 ± 0.21a |
| 1.37 ± 0.18b |
| |||||
| C+ | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00d |
| 0.00 ± 0.00b |
| 4.94 ± 0.00b |
| |||||
|
| |||||||||||||
| Eicosadienoic acid (C20:2) |
| 1.20 ± 0.00c |
| 48.72 ± 2.74a |
| 20.91 ± 4.18b |
| 21.48 ± 3.81b |
| 0.00 ± 0.00b |
| ||
|
| 1.42 ± 0.00b |
| 39.21 ± 1.67b |
| 40.96 ± 4.85a |
| 27.80 ± 3.69a |
| 0.00 ± 0.00b |
| |||
| C | 0.00 ± 0.00d |
| 0.00 ± 0.00c |
| 3.16 ± 0.56c |
| 0.00 ± 0.00b |
| 1.57 ± 0.44a |
| |||
| C+ | 2.56 ± 0.00a |
| 0.00 ± 0.00c |
| 3.78 ± 0.19c |
| 1.25 ± 0.00a |
| 0.00 ± 0.00b |
| |||
Values are means ± SEM of three replicates.
a-d Different letters between rows (treatments) for each TFA show significant differences P<0.05 by Duncan.
A-D Different letters between columns (processing time) for each TFA show significant differences P<0.05 by Duncan.
Figure 1Modulated Differential Scanning Calorimetry (MDSC) curves indicating exothermic/endothermic total heat flow (a) and nonreversible heat flow (b) for salami lipid fraction in prefermentation stage (--) and postripening stage (- -).
Onset temperature of the endothermic peak (To), maximum temperature (Tmax), and enthalpy (ΔH) of the lipid fractions of salami treatment Ls-Sc in the pre-fermentation and postripening stages.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
| Δ |
|
| Δ | |
| Pre-fermentation | 15.750 | 22.380 | 1.275 | 16.750 | 24.820 | 4.884 |
| 32.700 | 35.780 | 0.371 | 37.980 | 43.290 | 0.881 | |
| 80.140 | 84.280 | 0.031 | ||||
|
| ||||||
| Post - ripening | 16.187 | 25.290 | 5.495 | 19.195 | 27.650 | 6.610 |
| 40.105 | 45.080 | 1.230 | 39.805 | 45.330 | 2.211 | |
Transitions of nonreversible and total heat flow, onset temperature of the endothermic peak (To), midpoint temperature (Tm), and specific heat (ΔCp) of lipid fractions of salami of treatment Ls-Sc in the prefermentation and postripening stages.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
| Δ |
|
| Δ | |
| Pre-fermentation | 13.140 | 13.260 | 0.076 | 16.220 | 16.740 | 0.443 |
| 16.430 | 16.860 | 0.098 | 27.510 | 28.670 | 0.538 | |
| 23.470 | 25.120 | 0.074 | 39.080 | 40.700 | 0.054 | |
| 28.637 | 29.033 | 0.020 | 44.110 | 46.450 | 0.227 | |
| 31.263 | 31.685 | 0.020 | 64.070 | 75.930 | 0.054 | |
| 43.695 | 47.340 | 0.166 | 81.410 | 93.180 | 0.096 | |
| 79.490 | 82.610 | 0.011 | ||||
| 93.840 | 96.820 | 0.024 | ||||
|
| ||||||
| Post-ripening | 13.270 | 13.400 | 0.269 | 16.105 | 16.775 | 0.642 |
| 17.380 | 16.650 | 0.134 | 29.230 | 31.150 | 0.759 | |
| 23.780 | 25.383 | 0.134 | 40.160 | 42.385 | 0.208 | |
| 27.445 | 29.130 | 0.305 | 47.105 | 48.905 | 0.360 | |
| 40.670 | 42.480 | 0.102 | 62.580 | 64.930 | 0.020 | |
| 47.075 | 49.535 | 0.262 | 82.845 | 92.950 | 0.046 | |
| 61.138 | 63.455 | 0.031 | ||||
| 94.485 | 97.095 | 0.023 | ||||
Myoglobin species (%), deoxymyoglobin (DMB), oxymyoglobin, (OMB) and metmyoglobin (MMB). Treatments with (Ls- Sc) and without starter culture addition (C); the superscript + indicates the addition of 50 ppm NaNO2.
|
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||||
|
| 0 | 32.06 ± 0.42 | a | A | 28.86 ± 0.84 | c | B | 30.18 ± 0.65 | a | C | 27.45 ± 0.65 | c | D |
| 1 | 29.18 ± 0.26 | d | A | 29.04 ± 0.15 | c | A | 26.04 ± 0.10 | b | C | 27.54 ± 0.05 | c | B | |
| 2 | 29.20 ± 0.52 | d | A | 28.42 ± 0.20 | c | B | 26.95 ± 0.99 | c | C | 32.26 ± 0.50 | a | D | |
| 3 | 29.84 ± 0.24 | c | A | 30.80 ± 0.42 | b | B | 24.14 ± 0.42 | d | C | 27.89 ± 0.62 | c | D | |
| 7 | 31.55 ± 0.12 | b | A | 30.66 ± 0.75 | b | B | 31.23 ± 0.70 | e | A,B | 28.67 ± 0.68 | b | C | |
| 14 | 28.75 ± 0.22 | e | A | 33.20 ± 0.93 | a | B | 28.61 ± 0.37 | a | A | 27.09 ± 0.15 | c | C | |
|
| |||||||||||||
|
| 0 | 18.56 ± 0.56 | d | A | 25.43 ± 0.93 | a | B | 20.58 ± 0.09 | a | C | 22.47 ± 0.84 | a | D |
| 1 | 20.80 ± 0.87 | b | A | 25.75 ± 0.43 | a | B | 24.21 ± 0.40 | b | C | 21.97 ± 0.48 | a | D | |
| 2 | 21.75 ± 0.69 | a | A | 22.60 ± 0.75 | b | B | 25.78 ± 0.86 | c | C | 17.80 ± 0.08 | c | D | |
| 3 | 21.76 ± 0.55 | a | A | 18.92 ± 0.24 | d | B | 27.72 ± 0.61 | d | C | 22.39 ± 0.67 | a | D | |
| 7 | 17.94 ± 0.46 | e | B | 19.94 ± 0.94 | c | A | 16.60 ± 0.75 | e | C | 19.84 ± 0.19 | b | A | |
| 14 | 20.13 ± 0.51 | c | A | 17.10 ± 0.79 | e | B | 16.01 ± 0.92 | e | C | 17.05 ± 0.67 | d | C | |
|
| |||||||||||||
|
| 0 | 49.98 ± 0.90 | b | A | 45.37 ± 0.59 | e | B | 49.66 ± 0.19 | b | A | 50.01 ± 0.68 | c | A |
| 1 | 50.34 ± 0.69 | b | A | 45.17 ± 0.08 | e | C | 49.57 ± 0.43 | b | B | 50.70 ± 0.48 | b | A | |
| 2 | 49.17 ± 0.21 | c | B | 48.99 ± 0.23 | d | B | 46.98 ± 0.50 | d | C | 49.93 ± 0.72 | c | A | |
| 3 | 48.60 ± 0.71 | d | A | 50.67 ± 0.73 | a | B | 47.65 ± 0.01 | c | C | 49.58 ± 0.64 | c | D | |
| 7 | 51.00 ± 0.86 | a | A | 49.52 ± 0.55 | c | B | 52.69 ± 0.39 | a | C | 51.76 ± 0.69 | a | D | |
| 14 | 51.09 ± 0.40 | a | A | 50.14 ± 0.05 | b | B | 52.32 ± 0.65 | a | C | 51.70 ± 0.08 | a | D | |
Values are means ± SEM of nine samples with five replicates.
a-e Different letters between rows (processing time) for each Myoglobin species show significant differences P<0.05 by Duncan.
A-D Different letters between columns (treatment) for each processing time and Myoglobin species show significant differences P<0.05 by Duncan.
Figure 2Dynamics of the microbial population during the processing of salami: fermentation at 21°C from 0 to 48 h and ripening at 17°C to 336 h (14 days). CNS (grey square), total bacterial count (black triangle), and LAB (white circle). Treatments Ls-Sc (a), Ls-Sc+ (b), C (c), and C+ (d). The bars indicate the confidence intervals.
Biokinetic parameter estimation using Baranyi and Roberts's model.
|
|
|
|
| |
|---|---|---|---|---|
| CNS |
| -0.0006 ± 0.0000 | g | - |
|
| 0.037 ± 0.002 | e,f,g | - | |
| C | 0.0007 ± 0.000 | g | - | |
| C+ | 0.164 ± 0.035 | a | - | |
|
| ||||
| LAB |
| 0.029 ± 0.001 | e,f,g | - |
|
| 0.067 ± 0.001 | c,d,e | 14.691 ± 0.200 | |
| C | 0.003 ± 0.0004 | g | - | |
| C+ | 0.052 ± 0.003 | e,f | - | |
|
| ||||
| Total count |
| 0.019 ± 0.003 | f,g | - |
|
| 0.034 ± 0.003 | e,f,g | - | |
| C | 0.108 ± 0.007 | b,c | - | |
| C+ | 0.098 ± 0.012 | c,d | - | |
Values are means ± SEM with six replicates.
Different letters show significant differences P<0.05 by Tukey test.
-∗ Parameter not calculated (λ< 3h).
Figure 3Dynamics of E. coli population during the processing of salami: fermentation at 21°C from 0 to 48 h and ripening at 17°C to 336 h (14 days). Treatments: Ls-Sc (grey square) and Ls-Sc+ (black circle). The bars indicate the confidence intervals.